Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Watson Pharmaceuticals, Inc. - SWOT Analysis (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 03/12/2008
- Report Title: Watson Pharmaceuticals, Inc. - SWOT Analysis
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 30
Watson Pharmaceuticals, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Watson Pharmaceuticals (Watson) is engaged in the development and manufacture of specialty and non-patented pharmaceutical products. The company markets a broad range of generic products for the nephrology, urology, pain management, and therapeutic dermatology markets. It operates manufacturing, distribution, research and development, and administrative facilities primarily in the US. Watson is headquartered in Corona, California and employs about 5,600 people. The company recorded revenues of $2,496.7 million during the financial year (FY) ended December 2007, an increase of 26.1% over 2006. The increase was primarily driven by strong product sales of oxycodone HCl controlled-release tablets and pravastatin sodium tablets in its generics segment during the year. The operating profit of the company was $255.7 million during FY2007, as compared to an opearting loss of $422.1 million in 2006. The net profit was $141 million in FY2007, as compared to a net loss of $445 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Watson Pharmaceuticals (Watson) is engaged in the development and manufacture of specialty and non-patented pharmaceutical products. The company markets a broad range of generic products for the nephrology, urology, pain management, and therapeutic dermatology markets. It operates manufacturing, distribution, research and development, and administrative facilities primarily in the US. Watson is headquartered in Corona, California and employs about 5,600 people. The company recorded revenues of $2,496.7 million during the financial year (FY) ended December 2007, an increase of 26.1% over 2006. The increase was primarily driven by strong product sales of oxycodone HCl controlled-release tablets and pravastatin sodium tablets in its generics segment during the year. The operating profit of the company was $255.7 million during FY2007, as compared to an opearting loss of $422.1 million in 2006. The net profit was $141 million in FY2007, as compared to a net loss of $445 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
